Related Experiment Video
Updated: Aug 15, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Prematurity is associated with abnormal airway function in childhood
M Galdès-Sebaldt1, J R Sheller, J Grogaard
1Department of Pediatrics, Vanderbilt University, Nashville, Tennessee 37232.
Insights
Premature birth, not hyaline membrane disease, causes lasting lung problems and increased airway reactivity in children. This study followed 49 children aged 10-13, assessing pulmonary function and airway hyperresponsiveness.
Area of Science:
- Pediatric Pulmonology
- Neonatal Medicine
- Respiratory Physiology
Background:
- Prematurity and hyaline membrane disease (HMD) are known risk factors for adverse respiratory outcomes.
- Long-term effects on pulmonary function and airway reactivity in school-aged children require further investigation.
Purpose of the Study:
- To assess the long-term impact of prematurity and HMD on lung function and airway hyperresponsiveness.
- To differentiate the effects of prematurity from HMD on respiratory health in children aged 10-13 years.
Main Methods:
- Pulmonary function tests (PFTs) and methacholine (MCh) challenges were conducted.
- 49 prematurely born children were grouped by birth weight (<1500g vs. >1500g) and HMD status.
- Results were compared to 27 age-matched, term-born controls.
Main Results:
- Children born weighing <1500g (Groups I & II) showed significantly altered FEV1 and RV/TLC ratios compared to controls, irrespective of HMD.
- Group I (low birth weight, no HMD) exhibited reduced FEF25-75%, Vmax50%, and DLCO.
- Increased airway reactivity was observed in Groups I and II, with higher percentages experiencing significant FEV1 and SGaw drops post-MCh challenge.
Conclusions:
- Prematurity, rather than HMD itself, is the primary driver of long-term pulmonary abnormalities.
- Premature birth leads to persistent deficits in lung function and increased nonspecific airway reactivity in children.
- Early-life respiratory insults from prematurity have lasting consequences on respiratory health.
Abstract:
To evaluate the long-term effect of prematurity and/or hyaline membrane disease (HMD) on pulmonary function and airway reactivity, we studied 49 prematurely born children aged 10 to 13 years. They were divided into three groups according to birth weight and HMD status: Groups I and II comprised the children weighing less than 1,500 g at birth, and Group III those whose birth weight exceeded 1,500 g. Children without HMD at birth were classified as Group I and those with HMD as Group II or III. We performed both pulmonary function tests and methacholine (MCh) challenges and compared the results with those of 27 age-matched controls born at term. We found that FEV1 and RV/TLC ratios were significantly different from control values in the groups with birth weights less than 1,500 g, regardless of their HMD status (Groups I and II). In Group I, results for FEF25-75%, Vmax50%, and DLCO were lower than those of controls. Airway reactivity was significantly increased in Groups I and II. A 20% drop in FEV1 after MCh challenge was found in 88%, 62%, 53%, and 36% of children in Groups I, II, and III and controls, respectively, and a 35% drop in SGaw occurred in 87%, 88%, 53%, and 59%. We conclude that prematurity and not HMD per se leads to long-term pulmonary abnormalities and to an increase in nonspecific airway reactivity.
Related Concept Videos
Breathing
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Other Pulmonary Disorders
Asthma I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

